During ESMO 2023, oncologists came together to discuss lung cancer data emerging from the congress and the potential implications for clinical practice in the US, Japan and China. The meeting co-hosts each shared their views on key lung cancer data from three abstracts presented during ESMO before opening up the discussion to the panel. Watch the on-demand video to hear what they had to say.

 

Panel

  • Prof. Li Zhang, Sun Yat-sen University Cancer Center, Guangzhou, China

  • Prof. Tetsuya Mitsudomi, Kindai University, Osaka, Japan

  • Prof. Pasi A. Jänne, Dana-Farber Cancer Institute, Boston (MA), USA

  • Prof. Xiuning Le, MD Anderson Cancer Center, Houston (TX), USA

 

Clinical Takeaways

  • Updated results show that BL-B01D1 has potential in treating NSCLC patients who progressed after standard therapies.
  • In the KEYNOTE-671, perioperative pembrolizumab regimen significantly improves overall survival in resectable NSCLC versus placebo.
  • In the FLAURA2 trial, combining platinum-pemetrexed with osimertinib improves PFS in EGFR-mutated advanced NSCLC patients as compared to osimertinib alone, with a manageable safety profile.

 

Clinical Trials

  • BL-B01D1 bispecific EGFRxHER3 antibody drug conjugate trial
  • KEYNOTE-671
  • APG-1252 with Osimertinib for EGFR-mutant NSCLC
  • FLAURA2
  • RAMOSE
  • MARIPOSA
  • Inform oncologists about the latest clinical insights in lung oncology presented during EMSO 2023
  • Understand the impact of the latest clinical insights on clinical practice in the US, Japan and China
Programme summary
  • clock Duration 43 MIN
  • clock Language(s) flag
Watch the video now
Share this programme
This educational programme is supported by an Independent Educational Grant from SystImmune and BeiGene Europe.
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from SystImmune and BeiGene Europe.
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
LUNG CONNECT

LUNG CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer, Pierre Fabre Laboratories and Boehringer Ingelheim.

Meet the experts Independent IME approved

Other programmes of interest

video Video
Oncology 
ADCs in HR+/HER2- metastatic breast cancer

Optimising treatment strategies and AE management

Experts
Dr Barbara Pistilli
Endorsed by
GRASP
ICAN international cancer advocacy network Biomarker Collaborative Exon20group
  • download Downloadable
    Resources
  • clock MIN
  • calendar May 2025

Educational programme supported by an Independent Educational Grant from AstraZeneca.
podcast Podcast

Episode

2

of 2

episode
Oncology 
The HER2 diagnostic and treatment landscape in NSCLC: Episode 2

Navigating common treatment scenarios in HER2-mutant non-small cell lung cancer

Experts
Dr Eric Singhi, Dr Isabel Preeshagul, Oncology Brothers (Moderators)
Endorsed by
ICAN international cancer advocacy network Biomarker Collaborative Exon20group
  • download Downloadable
    Resources
  • clock 18 MIN
  • calendar Apr 2025

Educational programme supported by an Independent Educational Grant from Bayer.
publication Publication
Oncology 
Emerging molecular testing paradigms in NSCLC management

Experts
Prof. Frédérique Penault-Llorca, Prof. Mark Socinski
  • download Downloadable
    Resources
  • clock 20 MIN
  • calendar Apr 2025

Educational programme supported by an Independent Educational Grant from Bayer.
animated-video Animated Video
Oncology 
Elacestrant in ER+/HER2- metastatic breast cancer with ESR1-mut tumors

An overview of the EMERALD subgroup analyses

Experts
Prof. Javier Cortés
  • download Downloadable
    Resources
  • clock 8 MIN
  • calendar Apr 2025

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only.
podcast Podcast

Episode

1

of 2

episode
Oncology 
The HER2 diagnostic and treatment landscape in NSCLC: Episode 1

A medical oncologist and a pathologist share their perspectives on best practices in identifying HER2-directed NSCLC

Experts
Prof. Fernando López-Ríos, MD, PhD, Dr Devika Das, Oncology Brothers (Moderators)
Endorsed by
ICAN international cancer advocacy network Biomarker Collaborative Exon20group
  • download Downloadable
    Resources
  • clock 20 MIN
  • calendar Apr 2025

Educational programme supported by an Independent Educational Grant from Bayer.
publication Publication
Oncology 
Survey on the evolving role of the oncology nurse in the USA

Survey findings presented at ONS 2025 and published in the journal Healthcare

Experts
Nina Grenon, Natasha Pinheiro, Karen Waldrop, Brittni Prosdocimo
  • download Downloadable
    Resources
  • clock 7 MIN
  • calendar Apr 2025

Educational programme supported by an Independent Educational Grant from Bayer.